Study of HuMax-CD20, a New Drug to Treat Early Stage Non-Hodgkin´s Follicular Lymphoma
Withdrawn before enrolling · Phase 1/Phase 2
Conditions studied: Lymphoma, Follicular
In brief
The purpose of this trial is to determine the safety and efficacy of HuMax-CD20 as a treatment for Follicular Lymphoma (FL).
Key facts
- Study ID
- NCT00092274
- Run by
- GlaxoSmithKline
- People needed
- 0
- Starts
- 2004-09-01
- Expected to finish
- 2005-01-01
- Last updated by the study team
- 2015-04-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Relapsed or refractory follicular lymphoma grade I-II
- Tumor verified to be CD20 positive
- CT scan showing demarcated lesions
You may not qualify if…
- Previous treatment with rituximab resulting in less than partial response
- Previous radioimmunotherapy
- Previous stem cell transplantation
- Received the following treatments within 4 weeks prior to entering this study:
- Anti-cancer therapy
- Glucocorticosteroids unless less than 10 mg prednisolone/day
- Radiotherapy
- Received Mitomycin C or Nitrosoureas within 6 weeks prior to entering this trial
- HIV positivity
- Hepatitis B or hepatitis C
- Uncontrolled or chronic bacterial, fungal or viral infection
- Other cancer diseases, except certain skin cancers, cervix cancer and breast cancer
- Certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, lung, heart, hormonal, nerve or blood diseases
- WHO performance status of 3 or 4
- If you are participating in another trial with a different new drug 4 weeks before you enter this trial
- Current participation in any other clinical study
- Pregnant or breast-feeding women
- Women of childbearing age who are unable or unwilling to use an IUD or hormonal birth control during the whole trial
Where it is running
- University of Iowa Hospitals and Clinics — Iowa City, Iowa, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.